The United States government has reportedly procured millions of doses of a vaccine against Monkeypox.
Vaccine manufacturer, Bavarian Nordic, announced a $119 million order from the US government.
“We are pleased to announce the exercise of the first options under our contract with the U.S. government to deliver a freeze-dried version of the smallpox vaccine with an improved shelf-life, which will be manufactured at our new fill and finish facility,” said the CEO of Bavarian Nordic, Paul Chaplin.
The purchase came after the first confirmed case of Monkeypox in the United States, which struck a man from Massachusetts.
According to the Danish company, Bavarian Nordic has collaborated with the US government since 2003 on the development, manufacturing, and distribution of a non-replicating smallpox vaccine to ensure that all populations, including those with weakened immune systems, are protected from smallpox.
Bavarian Nordic confirmed that the US Department of Health and Human Services (HHS) has received almost 30 million doses of the liquid-frozen smallpox vaccine from the company to date.
Chaplin expressed that the procurement “Marks a significant milestone in our long-standing partnership with the U.S. government to ensure the availability of life-saving vaccines for the entire population.”
Bavarian Nordic also confirmed that the US government has the option to purchase an additional $180 million if it desired.
© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.